Streetbeat News

Stock Prices

GILD

Gilead Sciences' shares rose following positive interim results from a Phase 3 trial of Lenacapavir, which showed a 96% reduction in HIV infections with twice-yearly administration.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:38 pm

FTXO

IAT

USB

U.S. Bancorp has announced a new $5 billion share repurchase program and a 2% increase in its quarterly dividend to 50 cents per share. The buyback will start in early 2025, and the dividend will be paid on October 15. USB shares are trading higher in premarket.

Portfolio Pulse from Nabaparna Bhattacharya

September 12, 2024 | 12:38 pm

GILD

Gilead Sciences announced positive interim results from a second Phase 3 trial of its drug Lenacapavir, which showed a 96% reduction in HIV infections with twice-yearly administration.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:36 pm

TEM

Tempus AI, Inc. (NASDAQ:TEM) has launched the beta version of 'olivia', an AI-enabled personal health concierge app. The app aims to help patients manage their health data more effectively by aggregating information, tracking symptoms, and preparing for medical appointments.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:36 pm

KUKE

KUKE Music Holding Limited has regained compliance with the New York Stock Exchange's (NYSE) listing standards. This development follows the company's efforts to meet the minimum share price requirement, ensuring its continued presence on the exchange.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:35 pm

SIG

Signet Jewelers reported a mixed Q2 2025 earnings with a sales decline but an EPS beat. The company is net debt positive and has a strong Q3 outlook, leading to a 12.7% premarket stock increase.

Portfolio Pulse from Anusuya Lahiri

September 12, 2024 | 12:34 pm

CING

Cingulate has initiated the final study for its lead ADHD treatment, CTx-1301, and has raised over $10 million in additional capital since mid-August.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:33 pm

JNJ

Johnson & Johnson (JNJ) announced results from a Phase 2 study on Rybrevant for lung cancer and recently agreed to acquire V-Wave for $600 million. The company offers a 3.01% annual dividend yield, translating to $1.24 per share quarterly. To earn $500 monthly from dividends, an investment of approximately $199,432 is needed. JNJ shares fell 1.5% to $164.82.

Portfolio Pulse from Avi Kapoor

September 12, 2024 | 12:33 pm

TPET

Trio Petroleum has successfully initiated oil production from its first well at the Asphalt Ridge Project in Utah. The company is using a downhole heater to reduce bitumen viscosity, facilitating the pumping process to the surface.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:33 pm

SPY

The USA Producer Price Index (PPI) for August increased by 1.7% year-over-year, which is slightly below the estimated 1.8% and lower than the previous month's 2.1%. This indicates a slower pace of inflation in producer prices.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:30 pm